Matches in Wikidata for { <http://www.wikidata.org/entity/Q93209592> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- Q93209592 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q93209592 description "scientific article published on 21 April 2020" @default.
- Q93209592 description "wetenschappelijk artikel" @default.
- Q93209592 description "наукова стаття, опублікована 21 квітня 2020" @default.
- Q93209592 name "Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance" @default.
- Q93209592 name "Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance" @default.
- Q93209592 type Item @default.
- Q93209592 label "Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance" @default.
- Q93209592 label "Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance" @default.
- Q93209592 prefLabel "Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance" @default.
- Q93209592 prefLabel "Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance" @default.
- Q93209592 P1433 Q93209592-A7DD0B4F-98D4-483D-927B-57136C7E11E7 @default.
- Q93209592 P1476 Q93209592-23825A1A-4E34-4AFA-B0E0-44A6C7BD367E @default.
- Q93209592 P2093 Q93209592-023DDF99-687F-471F-9C31-6C2F4559D1D1 @default.
- Q93209592 P2093 Q93209592-05179B35-8C1B-4BAA-8471-3737CE583388 @default.
- Q93209592 P2093 Q93209592-065395AA-F3ED-4AD8-B015-ECF1BAD09A54 @default.
- Q93209592 P2093 Q93209592-0E30F19B-D47A-4818-A94A-DFFCA7C6E0F7 @default.
- Q93209592 P2093 Q93209592-15586767-5057-41AF-9D9B-8BBF5266F28C @default.
- Q93209592 P2093 Q93209592-1B9E9B0A-2ACC-4C3A-A3C9-5C7EACAD4065 @default.
- Q93209592 P2093 Q93209592-244811BC-5CAB-4FE4-83F2-316D430847BF @default.
- Q93209592 P2093 Q93209592-2728CEFA-576D-4CB1-861B-A95101CB26DD @default.
- Q93209592 P2093 Q93209592-3ACA35E6-1CEB-40A0-95CE-B05E974B8980 @default.
- Q93209592 P2093 Q93209592-4ED4C26F-570D-4B67-A256-05556CD6A648 @default.
- Q93209592 P2093 Q93209592-53CDF037-19D4-4436-9F7D-2A7428166517 @default.
- Q93209592 P2093 Q93209592-5D3A85D9-3BEC-4E12-A5F0-7E9D7D6E97A7 @default.
- Q93209592 P2093 Q93209592-644A9D24-C48A-48FB-BF00-0DF7A46B3163 @default.
- Q93209592 P2093 Q93209592-64ED7989-3E03-4990-AD13-58B20B2D9944 @default.
- Q93209592 P2093 Q93209592-6A5838AF-1F17-43AB-909E-44F3F944180E @default.
- Q93209592 P2093 Q93209592-70B1248B-3700-4B3D-9BBE-EBA6301959A0 @default.
- Q93209592 P2093 Q93209592-81F0CCA6-F7F7-4582-949E-3D45DEBB7B0F @default.
- Q93209592 P2093 Q93209592-95B16B72-E2C6-4E33-A685-840801FBC896 @default.
- Q93209592 P2093 Q93209592-9CB5105D-A650-4874-860F-33535037D2EE @default.
- Q93209592 P2093 Q93209592-A5DBB460-5CA1-4A6F-B775-E4BD2A175A8B @default.
- Q93209592 P2093 Q93209592-A6F4CD5C-F86D-4E6C-84A9-89BF3D320D53 @default.
- Q93209592 P2093 Q93209592-AF5C3BF2-4431-41EC-B179-41C4DEC796F7 @default.
- Q93209592 P2093 Q93209592-B6EA0F18-58FE-4957-9BF6-758099121F5C @default.
- Q93209592 P2093 Q93209592-C0E2FE07-F0C2-4554-A475-09FB781E21DE @default.
- Q93209592 P2093 Q93209592-C1F8744A-1749-41FF-BDB9-62BFE55EF6EE @default.
- Q93209592 P304 Q93209592-FCDC4A55-AD50-47B5-A5CE-52D2815A846C @default.
- Q93209592 P31 Q93209592-715881DB-0D99-4EC6-A9B4-53D96D6BDABE @default.
- Q93209592 P356 Q93209592-750F7596-8FA1-41EC-99AD-05CFD9D70A96 @default.
- Q93209592 P478 Q93209592-0A857B2E-9830-4422-B3A5-8344424F5AD1 @default.
- Q93209592 P50 Q93209592-01137741-ED30-4BFC-B3A2-2B931C55B752 @default.
- Q93209592 P577 Q93209592-9BF69F5D-E539-4D8E-B1A5-07C6AF7C7749 @default.
- Q93209592 P698 Q93209592-0E7EF217-4F5B-4442-BDEC-E0276D2D87D6 @default.
- Q93209592 P921 Q93209592-26E8BB59-3A39-4F39-8431-B5FFE122A146 @default.
- Q93209592 P932 Q93209592-0C193100-2A3F-4FFA-8777-3828B694D984 @default.
- Q93209592 P356 J.EBIOM.2020.102699 @default.
- Q93209592 P698 32330875 @default.
- Q93209592 P1433 Q24912341 @default.
- Q93209592 P1476 "Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance" @default.
- Q93209592 P2093 "Andreas David Zimmer" @default.
- Q93209592 P2093 "Bedair Dewidar" @default.
- Q93209592 P2093 "Biljana Blagojevic" @default.
- Q93209592 P2093 "Carolina De La Torre" @default.
- Q93209592 P2093 "Christoph Meyer" @default.
- Q93209592 P2093 "Costas A Lyssiotis" @default.
- Q93209592 P2093 "Darko Castven" @default.
- Q93209592 P2093 "Jens U Marquardt" @default.
- Q93209592 P2093 "Jonathan Sleeman" @default.
- Q93209592 P2093 "Julia Lochead" @default.
- Q93209592 P2093 "Li Zhang" @default.
- Q93209592 P2093 "Marina Pasca di Magliano" @default.
- Q93209592 P2093 "Matthew H Ward" @default.
- Q93209592 P2093 "Matthias Philip Ebert" @default.
- Q93209592 P2093 "Mei Han" @default.
- Q93209592 P2093 "Nadia Battello" @default.
- Q93209592 P2093 "Pavlo Holenya" @default.
- Q93209592 P2093 "Peter Sajjakulnukit" @default.
- Q93209592 P2093 "Sharon Pereira" @default.
- Q93209592 P2093 "Stefan Wölfl" @default.
- Q93209592 P2093 "Steven Dooley" @default.
- Q93209592 P2093 "Ute Hofmann" @default.
- Q93209592 P2093 "Verodia Charlestin" @default.
- Q93209592 P2093 "Weronika Piorońska" @default.
- Q93209592 P2093 "Zeribe Chike Nwosu" @default.
- Q93209592 P304 "102699" @default.
- Q93209592 P31 Q13442814 @default.
- Q93209592 P356 "10.1016/J.EBIOM.2020.102699" @default.
- Q93209592 P478 "54" @default.
- Q93209592 P50 Q78705292 @default.
- Q93209592 P577 "2020-04-21T00:00:00Z" @default.
- Q93209592 P698 "32330875" @default.
- Q93209592 P921 Q623031 @default.
- Q93209592 P932 "7182727" @default.